Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OSTX is 14.13M and currently, short sellers hold a 0.46% of that float. On February 05, 2025, OSTX’s average trading volume was 463.93K shares.
OSTX) stock’s latest price update
The stock of OS Therapies Inc (AMEX: OSTX) has increased by 10.29 when compared to last closing price of 1.75.Despite this, the company has seen a loss of -25.77% in its stock price over the last five trading days. businesswire.com reported 2025-02-04 that NEW YORK–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today provided a corporate update to the marketplace to contextualize recent positive clinical data, corporate and financial developments. “January 2025 was the most significant month in the Company’s history,” said Paul Romness, MHP, Chairman & CEO of OS Therapies. “We started OS Therapies because someone very clos.
OSTX’s Market Performance
OSTX’s stock has fallen by -25.77% in the past week, with a monthly drop of -53.83% and a quarterly drop of -26.34%. The volatility ratio for the week is 27.18% while the volatility levels for the last 30 days are 22.37% for OS Therapies Inc The simple moving average for the past 20 days is -42.32% for OSTX’s stock, with a -40.21% simple moving average for the past 200 days.
OSTX Trading at -40.39% from the 50-Day Moving Average
After a stumble in the market that brought OSTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.43% of loss for the given period.
Volatility was left at 22.37%, however, over the last 30 days, the volatility rate increased by 27.18%, as shares sank -54.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.04% upper at present.
During the last 5 trading sessions, OSTX fell by -25.77%, in comparison to the 20-day moving average, which settled at $3.3460. In addition, OS Therapies Inc saw -54.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSTX starting from Auerbach Shalom, who sale 16,720 shares at the price of $6.74 back on Jan 15 ’25. After this action, Auerbach Shalom now owns 2,531,211 shares of OS Therapies Inc, valued at $112,609 using the latest closing price.
Stock Fundamentals for OSTX
The total capital return value is set at 8.24.
Currently, EBITDA for the company is -4.34 million with net debt to EBITDA at 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.76.
Conclusion
To wrap up, the performance of OS Therapies Inc (OSTX) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
